Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • hollystephens723
    Member
    • Dec 2018
    • 36

    #1

    Check Out The Upcoming Federal Crowdsourcing Webinar Series

    Did you know that the U.S. Food and Drug Administration (FDA) regulates products that account for roughly 25% of the U.S. economy? That’s right: The Agency reviews and approves a lot more than drugs and vaccines. Its purview extends to medical devices, dietary supplements, foods, and more—and it’s constantly monitoring for their potential health risks to the public.

    PrecisionFDA, a secure, cloud-based platform that aids the study and analyses of large biological datasets, is helping to inform big data analyses by hosting crowdsourced data science challenges.

    If you are interested in learning more about precisionFDA’s mission and how they help monitor FDA regulated products, you can virtually attend the next Federal Crowdsourcing Webinar Series: A precisionFDA Strike for Public Health, hosted by Challenge.gov and Digital.gov on May 12th. Event participants will learn how crowdsourced challenges are helping the FDA better understand evolving areas of science around large biological data sets and apply that understanding to inform regulatory science.

    For more information and to register, please visit Digital.gov!

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    10-30-2026, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
74 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...